Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Atrial Fibrillation
100%
Stable Coronary Artery Disease
65%
Hazard Ratio
55%
Liraglutide
45%
Type 2 Diabetes Mellitus (T2DM)
43%
All-cause Mortality
42%
Placebo
42%
Middle-aged
38%
Heart Disease
34%
95% Confidence Interval
33%
Heart Rate Variability
30%
Coronary Artery Disease
30%
Ischemic Stroke
29%
N-terminal pro-B-type Natriuretic Peptide (NT-proBNP)
29%
Infarction
29%
Patients with Coronary Artery Disease
28%
Acute Myocardial Infarction
27%
Acute Heart Failure
27%
Incident Atrial Fibrillation
25%
New-onset Type 2 Diabetes
25%
Verapamil
25%
Clarithromycin
24%
Left Atrial Function
24%
C-reactive Protein
24%
Systolic Blood Pressure
23%
Metformin
23%
Cardiovascular Mortality
22%
Cardiovascular Events
21%
Copenhagen
20%
Early-onset Atrial Fibrillation
20%
Randomized Trial
20%
Aortic Stenosis
19%
Elderly Subjects
19%
10-year Follow-up
19%
Silent Myocardial Ischemia
19%
Non-severe
19%
Population-based
19%
Excessive Supraventricular Ectopic Activity
18%
Older Subjects
18%
Risk Factors
18%
Heart Failure
17%
Denmark
17%
Ventricular Arrhythmia
17%
Poor Prognosis
16%
Stroke Risk
16%
Prognostic Significance
16%
Computed Tomography
16%
Prognostic Value
15%
Pulmonary Congestion
15%
Night-time Heart Rate
15%
Medicine and Dentistry
Coronary Artery Disease
80%
Atrial Fibrillation
62%
Maturity Onset Diabetes of the Young
62%
Liraglutide
58%
Placebo
48%
Hazard Ratio
44%
All Cause Mortality
32%
Apoplexy
30%
Heart Rate Variability
29%
Middle Age
28%
Acute Decompensated Heart Failure
27%
Blood Pressure
27%
Congestive Heart Failure
26%
Aortic Stenosis
25%
Heart Disease
24%
Myocardial Infarction
24%
Cardiovascular System
23%
Computer Assisted Tomography
23%
Systolic Blood Pressure
23%
Troponin T
23%
Glycon
22%
Cohort Analysis
20%
Observational Study
20%
Glucagon-Like Peptide-1 Agonist
20%
Patient with Type 2 Diabetes
18%
Acute Heart Infarction
18%
Brain Natriuretic Peptide
17%
Glucose
17%
C Reactive Protein
17%
Brain Ischemia
16%
Cardiovascular Disease
16%
Echocardiography
16%
Hypertension
15%
Lung Congestion
15%
Electrocardiogram
15%
Diseases
15%
Amino Terminal Sequence
15%
Nonsustained Ventricular Tachycardia
15%
Prevalence
14%
Dyspnea
14%
Inflammation
14%
Beta Cell
13%
Long Term Exposure
13%
Randomized Controlled Trial
13%
Randomized Clinical Trials
13%
Silent Myocardial Ischemia
12%
Aortic Valve Stenosis
12%
Traffic Noise
12%
P Wave
12%
Heart Left Ventricle Ejection Fraction
12%
